Skip to main content
Caplight Logo









AbTx

AbTx

Private
BesançonHealthcare & Life Scienceshttps://www.abtx-bio.com/

Last Round

Crowdfunding

Mar 31, 2026

Est. Valuation

$5.01M

Total Funding Raised

$790,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AbTx is a biotechnology company that develops next-generation antibody-drug conjugates (ADCs) and antibody fragment conjugates (FDCs) for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

immuno-oncologyantibody-drug conjugatesADCantibody fragment-drug conjugatesFDCenzymatic conjugationsolid tumor therapybioconjugationtargeted cancer therapybiotech licensingpreclinical oncologydrug discovery platformnext-gen biologicsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AbTx Comparables

Compare AbTx with similar companies based on industry and business-model similarity.

AbTx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Creasallis
82%
Antikor Biopharma
82%
Crescendo Biologics Ltd.
79%

AbTx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingMar 31, 2026

Key People

Founding team and executive leadership

Boris Vuillermoz

CTO and co-founder

Founding Team

Meddy El Alaoui

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 99% MoM.

  • Mar 31, 2026

    $790K raised in a crowdfunding round.

AbTx Filings

Explore SEC and related filing metadata, where available.

AbTx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AbTx's valuation, stock price, and market status.

Is AbTx a public or private company?

AbTx is a private company.

What is the current stock price of AbTx?

AbTx is a private company with no public stock price. No recent secondary market data is available.

How much is AbTx worth (valuation)?

AbTx's valuation is estimated at $5.0M based on funding round data.

Can I buy AbTx stock?

AbTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AbTx's last funding round?

AbTx's most recent funding round was Crowdfunding on March 31, 2026.

Who are the main investors in AbTx?

Investor information for AbTx is not publicly disclosed.

Will AbTx IPO soon?

No public IPO plans have been announced for AbTx.

How can I track AbTx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AbTx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBesançon
Employee Range5
Year Founded2025
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?